Led En Carta Diagnostics' €5M seed round for at-home molecular diagnostics (Lyme disease, STIs).
En Carta Diagnostics is focused on transforming point-of-care diagnostics with a new generation of early Lyme disease diagnostics that can detect infection directly at the tick bite site, enabling quick intervention and prevention of Lyme disease progression
En Carta Diagnostics is focused on transforming point-of-care diagnostics with a new generation of early Lyme disease diagnostics that can detect infection directly at the tick bite site, enabling quick intervention and prevention of Lyme disease progression.